IRIS Institutional Research Information System - OPENBS Open Archive UniBS

PIANTONI, SILVIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.576
AS - Asia 1.319
EU - Europa 1.247
SA - Sud America 230
Continente sconosciuto - Info sul continente non disponibili 87
AF - Africa 36
OC - Oceania 6
Totale 5.501
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.515
SG - Singapore 503
CN - Cina 343
IT - Italia 297
DE - Germania 217
BR - Brasile 192
HK - Hong Kong 151
PL - Polonia 139
FI - Finlandia 125
VN - Vietnam 96
UA - Ucraina 95
GB - Regno Unito 86
FR - Francia 76
BD - Bangladesh 68
RU - Federazione Russa 61
TR - Turchia 40
IE - Irlanda 33
CA - Canada 32
SE - Svezia 32
IN - India 22
NL - Olanda 22
MX - Messico 14
ZA - Sudafrica 13
JP - Giappone 12
AR - Argentina 11
IQ - Iraq 11
ES - Italia 10
AT - Austria 9
CO - Colombia 9
ID - Indonesia 9
PK - Pakistan 9
SA - Arabia Saudita 8
MK - Macedonia 7
BE - Belgio 6
CZ - Repubblica Ceca 6
GR - Grecia 6
KR - Corea 6
PH - Filippine 6
AU - Australia 5
MA - Marocco 5
TN - Tunisia 5
AZ - Azerbaigian 4
CR - Costa Rica 4
EG - Egitto 4
JO - Giordania 4
KE - Kenya 4
PT - Portogallo 4
TW - Taiwan 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
CH - Svizzera 3
CL - Cile 3
DO - Repubblica Dominicana 3
EC - Ecuador 3
LT - Lituania 3
MY - Malesia 3
PY - Paraguay 3
VE - Venezuela 3
BG - Bulgaria 2
BO - Bolivia 2
ET - Etiopia 2
EU - Europa 2
IL - Israele 2
JM - Giamaica 2
KG - Kirghizistan 2
KZ - Kazakistan 2
NI - Nicaragua 2
PS - Palestinian Territory 2
UY - Uruguay 2
UZ - Uzbekistan 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BM - Bermuda 1
CY - Cipro 1
GE - Georgia 1
GT - Guatemala 1
GY - Guiana 1
IS - Islanda 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
MZ - Mozambico 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
UG - Uganda 1
Totale 5.416
Salva come PNG Salva come JPEG
Città #
Ashburn 313
Singapore 287
Fairfield 222
San Jose 170
Hong Kong 149
Warsaw 136
Woodbridge 118
New York 103
Beijing 96
Chandler 91
Houston 90
Seattle 90
The Dalles 86
Cambridge 84
Helsinki 84
Jacksonville 81
Wilmington 76
Dallas 73
Munich 63
Princeton 58
Los Angeles 55
Council Bluffs 54
Ann Arbor 44
Brescia 39
Lauterbourg 34
Dublin 33
Turku 33
Ho Chi Minh City 32
Istanbul 30
Milan 30
Columbus 27
Hanoi 24
San Francisco 23
São Paulo 23
Buffalo 20
Santa Clara 20
Redondo Beach 19
London 16
Moscow 16
Shanghai 16
Chicago 15
Des Moines 15
Orem 14
Rome 13
San Diego 13
Bergamo 12
Denver 12
Nanjing 12
Brooklyn 11
Johannesburg 11
Changsha 10
Montreal 10
Nuremberg 10
Tokyo 10
Amsterdam 8
Atlanta 8
Nanchang 8
Salò 8
Stockholm 8
Chennai 7
Dhaka 7
Vienna 7
Belo Horizonte 6
Boardman 6
Brussels 6
Ferrara 6
Frankfurt am Main 6
Mexico City 6
Passirano 6
Phoenix 6
Shenyang 6
Toronto 6
Turin 6
Vancouver 6
Albuquerque 5
Bogotá 5
Erbil 5
Haikou 5
Jiaxing 5
Lappeenranta 5
Miami 5
Ningbo 5
Nürnberg 5
Paris 5
Rio de Janeiro 5
Amman 4
Ankara 4
Baku 4
Bosio 4
Cairo 4
Dong Ket 4
Dosso 4
Guangzhou 4
Hangzhou 4
Hebei 4
Jakarta 4
Jinan 4
Nairobi 4
Ninh Bình 4
Olomouc 4
Totale 3.474
Salva come PNG Salva come JPEG
Nome #
9A.07: CARDIOVASCULAR TARGET ORGAN DAMAGE IN PREMENOPAUSAL SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS AND IN CONTROLS. ARE THERE ANY DIFFERENCES? 344
COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case–control study 222
Decreased circulating t regulatory lymphocytes in obese patients undergoing bariatric surgery 196
Relationship Between Different Subpopulations of Circulating CD4+ T-lymphocytes and Microvascular Structural Alterations in Humans 189
Effector T-cells are expanded in systemic lupus erythematosus patients with high disease activity and damage indexes 187
Cardiovascular target organ damage in premenopausal systemic lupus erythematosus patients and in controls: Are there any differences? 186
Prevalence and disease-specific risk factors for Lower Urinary Tract symptoms in Systemic Sclerosis: an international multi-centric study 183
Anti-carbamylated protein antibodies as a clinical response predictor in rheumatoid arthritis patients treated with abatacept 178
Autoantibodies' titre modulation by anti-BlyS treatment in systemic lupus erythematosus. 177
Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome 175
Association Between Changes in BLyS Levels and the Composition of B and T Cell Compartments in Patients With Refractory Systemic Lupus Erythematosus Treated With Belimumab 174
Relationship between different subpopulations of circulating CD4+ T lymphocytes and microvascular or systemic oxidative stress in humans 169
The limited cutaneous form of systemic sclerosis is associated with urinary incontinence: an international multicentre study 159
Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome 156
Anti-inflammatory action of colchicine in hospitalised patients with COVID-19. Response to: 'Colchicine treatment in community healthcare setting to prevent severe COVID-19' by Della-Torre et al 152
Characterization of B- and T-Cell Compartment and B-Cell Related Factors Belonging to the TNF/TNFR Superfamily in Patients With Clinically Active Systemic Lupus Erythematosus: Baseline BAFF Serum Levels Are the Strongest Predictor of Response to Belimumab after Twelve Months of Therapy. 146
Bridging the Diagnostic Gap for Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders: Evidence of a Common Extracellular Matrix Fragmentation Pattern in Patient Plasma as a Potential Biomarker 144
Circulating follicular helper T cells (CD4+CXCR5+ICOS+) decrease in patients with rheumatoid arthritis treated with abatacept 142
Predictive factors of abatacept therapy discontinuation in patients with rheumatoid arthritis 136
Undifferentiated connective tissue disease: the diagnoses critically revised-experience of a single center 132
A Narrative Review of Pathogenetic and Histopathologic Aspects, Epidemiology, Classification Systems, and Disease Outcome Measures in Systemic Sclerosis 126
Pathophysiological role and therapeutic implications of vitamin d in autoimmunity: Focus on chronic autoimmune diseases 124
Frequency of positive antiphospholipid antibodies in pregnant women with SARS-CoV-2 infection and impact on pregnancy outcome: A single-center prospective study on 151 pregnancies 124
The Influence of Treatment of Inflammatory Arthritis During Pregnancy on the Long-Term Children's Outcome. 121
Coagulation dysfunction in COVID-19: The interplay between inflammation, viral infection and the coagulation system 119
The rationale for the use of colchicine in COVID-19: comments on the letter by Cumhur Cure M et al 119
Why not to use colchicine in COVID-19? An oldanti-inflammatory drug for a novel auto-inflammatory disease 114
Pregnancy in antiphospholipid syndrome: what should a rheumatologist know? 98
Calprotectin as a biomarker in rheumatoid arthritis: the potential predictive value of response to treatment 96
Reply to: Anti-carbamylated protein antibodies are associated with early abatacept response in rheumatoid arthritis by Castellanos-Moreira et al 96
CXCL-13 serum levels in patients with rheumatoid arthritis treated with abatacept 96
Regulation of neutrophil associated RNASET2 expression in rheumatoid arthritis 95
The IMMENSE Study: The Interplay Between iMMune and ENdothelial Cells in Mediating Cardiovascular Risk in Systemic Lupus Erythematosus 95
Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome 88
Endothelial Dysfunction in Systemic Lupus Erythematosus and Systemic Sclerosis: A Common Trigger for Different Microvascular Diseases 84
Multiparametric autoantibody analysis: a new paradigm for the diagnosis of connective tissue diseases 71
Editorial: Into the heart of systemic autoimmune diseases. 68
Response to: 'Correspondence on 'Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome'' by Kawada 68
Urinary incontinence in systemic sclerosis: a prospective multicentre cohort study 60
Multicenter study to improve clinical interpretation of anticardiolipin and anti-β2-glycoprotein I antibody test results for diagnosis of antiphospholipid syndrome 29
Diagnostic performance of particle-based multi-analyte technology compared to indirect immunofluorescence in screening for anti-nuclear antibodies in patients with autoimmune rheumatic diseases 23
Potential role of the spleen in the development of arterial hypertension in humans 19
AB1311 EVALUATION OF A POTENTIAL INDUCTION OF AUTOANTIBODIES IN A COHORT OF PATIENTS AFFECTED BY RHEUMATOID ARTHRITIS, SYSTEMIC SCLEROSIS OR WITH TRIPLE POSITIVITY FOR ANTIPHOSPHOLIPID ANTIBODIES FOLLOWING ANTI-SARS-CoV2 VACCINATION 13
AB0706 CIRCULATING HELPER T AND INNATE LYMPHOID CELLS IN A COHORT OF bDMARDs-NAÏVE PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH ABATACEPT 8
Totale 5.501
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.817
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.817
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022271 0 0 9 29 3 26 14 17 15 51 44 63
2022/2023250 33 8 7 19 27 62 3 28 46 0 7 10
2023/2024419 23 11 57 44 22 82 12 63 60 6 2 37
2024/2025933 9 19 21 110 71 83 57 54 96 94 181 138
2025/20261.933 176 229 145 235 197 153 297 85 97 175 71 73
2026/2027239 73 126 40 0 0 0 0 0 0 0 0 0
Totale 5.501